Tarde intensa repasando ASCOGU23, gracias a la organización y bonito agradecimiento de la Dra Martínez Ortega, somos SOGUG#

Catching up with Dr. Tannir at #ASCOGU23 , a man who commits his life of hard work to rare kidney cancer. He still remembers me and Joey, after 10 years.

ASCO Daily News article about our abstract and poster to be presented at #ASCOGU23

ctDNA Status Pretreatment Predicts Outcomes Better Than Pathologic Complete Response in Patients With Muscle-Invasive Bladder Cancer dailynews.ascopubs.org/do/ctdna-statu…

!! ASCOGU 2023 desde San Francisco !!

La segunda parte de nuestra cobertura en ASCO GU ya se ha lanzado.

Podéis verla aquí: congressbites.tv/joinus

Gracias a nuestros expertos: Enrique Grande Elena Castro Guillermo de Velasco

#ASCOGU23 #oncología #cancer #prostatecancer

#ASCOGU23

A great opportunity presented @asco #ASCOGU23 to ask Dr Ned Sharpless about American innovative treatments being trialled here. Clearly NCI Center for Cancer Research President Biden support working with us CancerTrialsIreland 🌈 NI Clinical Research Network

How to use PARIi? When?
Which combination? All comers? Only BRCAm?
#ASCOGU23 #PROpel #TALAPRO2

Our extraordinaire third year fellow showcasing her research at ASCO GU2023! #ASCOGU23 #GU23 Markey Cancer Center Trainees Markey Cancer Center University of Kentucky Hem-Onc Fellows Network

Flying to SF to attend to ASCO GU #ASCOGU23

#ASCOGU23 A unique opportunity for exchanging ideas and meeting great people! Petros Grivas Dimitra Bakaloudi MD, MS Minas Economides, MD

I am also proud for my first poster presentation!
Check our poster on SG following EV meetings.asco.org/abstracts-pres…
Jean Hoffman-Censits
Looking forward to next time!!

#ASCO GU23 is a great way to reconnect with colleagues and former UTHealth Houston IM Residency co-residents! Jennifer Swails #GU23 #ASCO

Thought provoking data from the RETAIN study by Dan Geynisman of Fox Chase. Despite not meeting primary endpoint, approaches to bladder preservation should be explored further. #ASCOGU23 ASCO OncoAlert

Tons of exceptional content at #ASCOGU23 . I was excited to learn about SAMURAI — the addition of STAMPEDE-style kidney-directed SBRT for metastatic RCC with IO-based systemic therapy. Brilliant. #radonc

Biopsy-free Radical Prostatectomy?

Presented at #ASCOGU23
Dr. Yi Cai

SUVmax above 14.60 (100% specificity)

Avoid biopsy and excludes gleason 6 prostate cancer before Radical Prostatectomy
UroTeragLATAM

A quick run to check out the ballpark in between meetings at #ASCOGU23 . Grateful Dead on the AirPods of course!

Our MD Anderson Cancer Center Genitourinary group at a lovely dinner @asco #ASCOGU23 . As I move along in my career, I realize that my coworkers are the biggest asset in our department. Andy Hahn Pavlos Msaouel Nazli Dizman #nizartannir Amishi Shah Eric Jonasch and many more who joined later.

Reflecting on an incredible experience taking my research on the road to #EAU23 , #ASCOGU23 and #SESAUA2023 ! From exploring new places to engaging in stimulating discussions, this academic adventure was truly unforgettable. Fortunate to be a part of Wake Forest Urology

Defendiendo el papel de la evaluación geriátrica en cáncer de próstata metastásico #oncogeriatria #ASCOGU23 @oncologia medica HospitalLaFe

#posterwalk in advanced stage #RCC : detectable #ctDNA showed a 90.9% concordance with progression (20/22); undetectable ctDNA showed an 83.3% concordance with progression-free survival (10/12). #ASCOGU23 Arnab Basu Alan Tan

Absolutely delighted to represent my program UToledo Medicine at #ASCOGU23 !